← Back to catalogue

Optune Pax

FDA PMAEUDAMED

Class III (US FDA PMA)

PMA P250034

by Novocure GmbH

Identity

Trade Name
Optune Pax FDA PMA
Generic Name
Low Electric Field Generator for Pancreatic Cancer Treatment FDA PMA

Identifiers

PMA Number
P250034 FDA PMA
FDA Product Code
SHC FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
General, Plastic Surgery FDA PMA
FDA Decision
APPR Approved FDA PMA

Optune Pax is a low electric field generator designed for the treatment of adult patients diagnosed with locally advanced pancreatic cancer. It is intended to be used in conjunction with gemcitabine and nab-paclitaxel chemotherapy regimens.

This device is manufactured by Novocure GmbH and is authorized under FDA PMA P250034. It is classified as a class 3 medical device and is intended for clinical application as specified in the regulatory documentation.

Frequently asked questions

What is the primary function of the Optune Pax?

The Optune Pax is a low electric field generator specifically designed to treat adult patients who have been diagnosed with locally advanced pancreatic cancer.

How is the Optune Pax used in a clinical setting?

The device is intended to be used concomitantly with gemcitabine and nab-paclitaxel, which are standard chemotherapy treatments for pancreatic cancer.

Is the Optune Pax authorized for medical use?

Yes, the device has received FDA PMA authorization under reference number P250034, confirming it has met the necessary regulatory requirements for its intended use.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Novocure GmbH
FDA Applicant
Novocure, GmbH

Sources (2)

  • FDA PMA P250034 24 fields · synced Sep 18, 2026
  • EUDAMED 1 fields · synced Jun 3, 2026